Innovations in Pharmacotherapy of Diabetes: A Review of Latest Reports

QR Code

Innovations in Pharmacotherapy of Diabetes: A Review of Latest Reports

Introduction and purpose Diabetes mellitus as one of the most pressing global health challenges of the 21st century, affects millions worldwide and contributes significantly to mortality by damaging multiple organs and burdens healthcare systems. The global rise in diabetes, especially Type 2 is...

Full description

Saved in:

Bibliographic Details
Main Authors:	Katarzyna Czechowska, Aleksandra Świerczewska, Piotr Komasara, Julia Nowakowska, Aleksandra Sędek, Lena MERCHEL, Ilona Bednarek, Sylwia Lach, Karol Seweryn Błąd, Kinga Kałuża
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2025-07-01
Series:	Journal of Education, Health and Sport
Subjects:	diabetes mellitus diabetes type 1 diabetes type 2 SGLT2 inhibitors GLP-1 agonists teplizumab
Online Access:	https://apcz.umk.pl/JEHS/article/view/61795
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

¿Combinamos AR-GLP1 + i-SGLT2? Sí o no
by: Claudia Folino
Published: (2024-10-01)

Prescribing Antidiabetic Medications Among GPs in Croatia—A Real-Life Cross-Sectional Study
by: Tomislav Kurevija, et al.
Published: (2025-06-01)

Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice
by: Gašper Tonin, et al.
Published: (2025-07-01)

Suboptimal physician adherence to evidence‐based guidelines for managing cardiorenal comorbidities in diabetes care: A retrospective single‐center study in Taiwan
by: Zong‐Yu Shen, et al.
Published: (2025-08-01)

Clinical use and monitoring of adverse effects of sodium‐glucose cotransporter‐2 inhibitors in persons with type 1 diabetes mellitus
by: Chinatsu Sakai, et al.
Published: (2025-08-01)

Evaluation of anxiety condition among type 1 and type 2 diabetic patients
by: Bulut A, et al.
Published: (2016-10-01)

Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk
by: Sara Palazzi, et al.
Published: (2025-06-01)

A case of severe ketoacidosis as the first clinical manifestation of type 2 diabetes mellitus in a youngster
by: Bruno Bombaci, et al.
Published: (2025-01-01)

Diabète et qualité de vie, Etude descriptive portant sur 40 diabétiques :type1 et 2, Réalisée à L’hôpital de jour des diabétiques de Oued Athmenia w de Mila.
by: Lakhdar AMRANE, et al.
Published: (2022-09-01)

The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes
by: Alan Sinclair, et al.
Published: (2025-06-01)

Early Recognition of Type 2 Diabetes Complications and Use of SGLT2i in Multidisciplinary Approach: Indonesian Perspective - An Expert Opinion
by: Aida Lydia, et al.
Published: (2023-01-01)

Gestational diabetes and parental type 2 diabetes as risk indicators for type 1 diabetes in offspring: a systematic review and meta-analysisResearch in context
by: Isabella Albanese, et al.
Published: (2025-07-01)

Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs?
by: Joana Nicolau, et al.
Published: (2025-07-01)

Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD)
by: Yuta Nakamura, et al.
Published: (2025-05-01)

Compare the Decrease in Visceral Adipose Tissue in People with Obesity and Prediabetes vs. Obesity and Type 2 Diabetes Treated with Liraglutide
by: Rosa Nayely Hernández-Flandes, et al.
Published: (2025-07-01)

The Clinically Significant Changes in the Composition and Functional Diversity of the Vaginal Microbiome in Women with Type 2 Diabetes Mellitus
by: Min Jeong Kim, et al.
Published: (2025-06-01)

Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors
by: Kyriaki Vafeidou, et al.
Published: (2025-05-01)

Is the Impact of Sodium–Glucose Co-Transporter 2 (SGLT2) Inhibitors on Bone Metabolism and Fracture Incidence a Class or Drug Effect? A Narrative Review
by: George I. Lambrou, et al.
Published: (2025-04-01)

Monocyte chemoattractant protein-1 in patients with different types of diabetes mellitus: clinical and practical significance
by: Ivan I. Golodnikov, et al.
Published: (2025-01-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)

Assessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review
by: Jacob Itkin, et al.
Published: (2025-06-01)

Flozins - modern treatment for patients with type 2 diabetes
by: Dominik Augustyn, et al.
Published: (2025-07-01)

New onset of type 1 and type 2 diabetes post-COVID-19 infection: a systematic review
by: Ahmed El-Naas, et al.
Published: (2025-12-01)

Editorial: Deciphering the immunological and neuronal regulators of diabesity
by: Chandan Sona, et al.
Published: (2025-07-01)

Canagliflozin and risk of amputation in patients with type 2 diabetes
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Weight Loss Effects of Once-Weekly Semaglutide 2.4 mg in Adults with and Without Type 2 Diabetes: A Systematic Review and Meta-Analysis
by: Boram Hong, et al.
Published: (2025-07-01)

Effectiveness of SGLT2 inhibitors compared to sulphonylureas for long-term glycemic control in type 2 diabetes: A meta-analysis
by: Zhouhong Zhan, et al.
Published: (2025-07-01)

Comparative study of oxidative stress in diabetes mellitus
by: Baghdad Science Journal
Published: (2013-03-01)

A Scoping Review of the Relationship Between Psychological (In)flexibility and Living with and Managing Type 1 and Type 2 Diabetes
by: Max Z. Roberts, et al.
Published: (2025-06-01)

Effects of Empagliflozin on Sarcopenia Risk, Body Composition, and Muscle Strength in Type 2 Diabetes: A 24-Week Real-World Observational Study
by: Deniz Çetin, et al.
Published: (2025-06-01)

Sodium-glucose cotransporter 2 Inhibitors and COVID-19 outcomes in type 2 diabetes patients: A population-based cohort study
by: Cerina Dubois, et al.
Published: (2025-07-01)

Clinical features analysis of fulminant type 1 diabetes mellitus
by: Min GAO, et al.
Published: (2025-06-01)

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM
by: T. V. Saprina, et al.
Published: (2013-06-01)

Mapping Barriers and Interventions to Diabetes Self-Management in Latino Youth: A Scoping Review
by: Milena de Lucca, et al.
Published: (2025-07-01)

Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
by: Vincenzo Trapanese, et al.
Published: (2025-05-01)

Ketoacidosis as unexpected adverse reaction SGLT<sub>2</sub> inhibitor
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Exploring the Incidence and Risk Factors of Diabetic Nephropathy in Type 1 Diabetes: Insights from a Retrospective Cohort Study in Northwest China
by: Du Z, et al.
Published: (2025-07-01)

Effect of Diabetes Self-Management Education on Knowledge and HbA1c Levels among Patients with Type 2 Diabetes Mellitus in Occupational Health Care
by: Susan Margarita, et al.
Published: (2025-06-01)

Uhrf1 downregulation promotes β‐cell dedifferentiation by decreasing Foxo1 expression in type 2 diabetes
by: Lanfang Fu, et al.
Published: (2025-08-01)